| - GRCh37:
- Chr3:154832915
- GRCh38:
- Chr3:155115126
| MME | L110* | Charcot-Marie-Tooth disease axonal type 2T | Likely pathogenic (Jul 10, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr3:154860050-154860058
- GRCh38:
- Chr3:155142261-155142269
| MME | | Charcot-Marie-Tooth disease axonal type 2T | Pathogenic (Aug 8, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr3:154836531
- GRCh38:
- Chr3:155118742
| MME | | Charcot-Marie-Tooth disease axonal type 2T | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr3:154834656
- GRCh38:
- Chr3:155116867
| MME | | Charcot-Marie-Tooth disease axonal type 2T, not provided | Pathogenic/Likely pathogenic (Sep 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154834298
- GRCh38:
- Chr3:155116509
| MME | I130T | Charcot-Marie-Tooth disease axonal type 2T, Inborn genetic diseases, not provided
| Uncertain significance (May 5, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154866352
- GRCh38:
- Chr3:155148563
| MME | E504V | Inborn genetic diseases, not provided | Uncertain significance (Nov 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154860085
- GRCh38:
- Chr3:155142296
| MME | R385Q | not provided, Charcot-Marie-Tooth disease axonal type 2T | Uncertain significance (May 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154858041
- GRCh38:
- Chr3:155140252
| MME | A306V | Charcot-Marie-Tooth disease axonal type 2T | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr3:154861356-154861357
- GRCh38:
- Chr3:155143567-155143568
| MME | H438fs | not provided, Charcot-Marie-Tooth disease axonal type 2T | Pathogenic/Likely pathogenic (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154836595-154836596
- GRCh38:
- Chr3:155118806-155118807
| MME | K239fs | Charcot-Marie-Tooth disease axonal type 2T | Likely pathogenic (Oct 21, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:154886415
- GRCh38:
- Chr3:155168626
| MME | | Charcot-Marie-Tooth disease axonal type 2T, not provided | Conflicting interpretations of pathogenicity (Sep 22, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:154889975
- GRCh38:
- Chr3:155172186
| MME | Q684* | not provided | Pathogenic/Likely pathogenic (Nov 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154832893
- GRCh38:
- Chr3:155115104
| MME | R103C | Charcot-Marie-Tooth disease axonal type 2T, not provided | Uncertain significance (Aug 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154866415
- GRCh38:
- Chr3:155148626
| MME | K525T | Charcot-Marie-Tooth disease axonal type 2T | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr3:154862224-154862225
- GRCh38:
- Chr3:155144435-155144436
| MME | R468fs | Charcot-Marie-Tooth disease axonal type 2T, not provided | Pathogenic/Likely pathogenic (Jan 9, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154884765
- GRCh38:
- Chr3:155166976
| MME | G579S | Spinocerebellar ataxia 43, not provided | Uncertain significance (Jul 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154832788
- GRCh38:
- Chr3:155114999
| MME | R68* | Charcot-Marie-Tooth disease axonal type 2T, not provided | Pathogenic/Likely pathogenic (Oct 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154834540
- GRCh38:
- Chr3:155116751
| MME | K177fs | Charcot-Marie-Tooth disease axonal type 2T, not provided | Pathogenic (Mar 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154889997
- GRCh38:
- Chr3:155172208
| MME | A691V | Charcot-Marie-Tooth disease axonal type 2T | Uncertain significance (Jul 11, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:154859862
- GRCh38:
- Chr3:155142073
| MME | Y347C | not provided, Hereditary breast ovarian cancer syndrome, Spinocerebellar ataxia 43, Charcot-Marie-Tooth disease axonal type 2T, not specified | Uncertain significance (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154861298
- GRCh38:
- Chr3:155143509
| MME | M419L | Charcot-Marie-Tooth disease axonal type 2T, Spinocerebellar ataxia 43, not provided
| Benign/Likely benign (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154890381
- GRCh38:
- Chr3:155172592
| MME | | Charcot-Marie-Tooth disease axonal type 2T, Spinocerebellar ataxia 43, not provided
| Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154886578
- GRCh38:
- Chr3:155168789
| MME | A658T | Charcot-Marie-Tooth disease axonal type 2T | Likely pathogenic (Oct 8, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:154884696
- GRCh38:
- Chr3:155166907
| MME | P556S | Charcot-Marie-Tooth disease axonal type 2T | Likely pathogenic (Oct 8, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:154834529
- GRCh38:
- Chr3:155116740
| MME | E172D | not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2T
| Uncertain significance (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154886279
- GRCh38:
- Chr3:155168490
| MME | | not provided | Pathogenic/Likely pathogenic (Jan 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154866405
- GRCh38:
- Chr3:155148616
| MME | Q522* | not provided | Pathogenic (Jun 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154834479
- GRCh38:
- Chr3:155116690
| MME | P156fs | Charcot-Marie-Tooth disease axonal type 2T, Spinocerebellar ataxia 43, not provided
| Pathogenic/Likely pathogenic (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154886404
- GRCh38:
- Chr3:155168615
| MME | G635D | Charcot-Marie-Tooth disease axonal type 2T | Uncertain significance (Mar 9, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:154861312
- GRCh38:
- Chr3:155143523
| MME | R425fs | Charcot-Marie-Tooth disease axonal type 2T, not provided | Conflicting interpretations of pathogenicity (May 31, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:154861308
- GRCh38:
- Chr3:155143519
| MME | A422D | not provided | Uncertain significance (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:154802027
- GRCh38:
- Chr3:155084238
| MME | W24* | Charcot-Marie-Tooth disease axonal type 2T | risk factor (Oct 6, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr3:154836533
- GRCh38:
- Chr3:155118744
| MME | | Charcot-Marie-Tooth disease axonal type 2T | Pathogenic (Jul 6, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr3:154834350
- GRCh38:
- Chr3:155116561
| MME | | Charcot-Marie-Tooth disease axonal type 2T | Pathogenic (Jul 6, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr3:154886361
- GRCh38:
- Chr3:155168572
| MME | C621R | Peripheral neuropathy | Likely pathogenic (Jul 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:154836541
- GRCh38:
- Chr3:155118752
| MME | Q221* | Charcot-Marie-Tooth disease axonal type 2T | Pathogenic (Jul 6, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr3:154834776
- GRCh38:
- Chr3:155116987
| MME | | Charcot-Marie-Tooth disease axonal type 2T | Pathogenic (Jul 6, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr2:220146774
- GRCh38:
- Chr2:219282052
| DNAJB2 | E115* | Charcot-Marie-Tooth disease axonal type 2T | Pathogenic (Oct 25, 2013) | criteria provided, single submitter |